OraVerse Local Anesthesia Reversal: 1 unit

$7.00
Write a Review

Reviews the unique new pharmaceutical agent OraVerse (phentolamine mesylate) for reversal of soft tissue anesthesia.  Durations of anesthesia following administration of OraVerse, administration protocols, adverse events, mechanisms of action, dosage protocols, costs of administration and clinical trials are addressed.